TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox [Yahoo! Finance]
TC BioPharm (Holdings) plc - American Depositary Shares (TCBP)
Company Research
Source: Yahoo! Finance
biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that it intends to begin Proof of Concept preclinical studies for its lead therapeutic TCB 008, for treatment in monkey pox. TCB008 is an allogeneic unmodified cell therapy that is made up of activated and expanded gamma delta T (GDT) cells which the company expects will have applications in treating the global health emergency. Due to the highly infectious nature of monkeypox, TCBP expects to partner with a leading Infectious Disease Center or University associated with a similar organization to rapidly advance the Proof-of-Concept and pre-clinical studies. "There are a number of academic papers highlighting a successful immune response to viral infection being heavily reliant on the presence of gamma delta t-cells," commented CEO Bryan Kobel . "We continue to look at avenues to expand the therapeutic applications for TCB008 and moving into rapid res
Show less
Read more
Impact Snapshot
Event Time:
TCBP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TCBP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TCBP alerts
High impacting TC BioPharm (Holdings) plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TCBP
News
- TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® GrantPR Newswire
- TCBP Provides Shareholder Update and Highlights Recent Milestone AchievementsPR Newswire
- TCBP Responds to False Social Media Claim [Yahoo! Finance]Yahoo! Finance
- TCBP Responds to False Social Media ClaimPR Newswire
- TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox TherapeuticPR Newswire
TCBP
Sec Filings
- 11/14/24 - Form SC
- 10/11/24 - Form 6-K
- 8/30/24 - Form 6-K
- TCBP's page on the SEC website